(Q66933280)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1132396%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

title

Antitumour immunity--1. Differential response of neuraminidase-treated and x-irradiated tumour vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1132396%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

Antitumour immunity—1. Differential response of neuraminidase-treated and X-irradiated tumour vaccine (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90030-4

10 October 2023

author name string

P. K. Ray

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1132396

24 August 2022

V. S. Thakur

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1132396

24 August 2022

K. Sundaram

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1132396

24 August 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1132396

24 August 2022

publication date

1 January 1975

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1132396%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

31 August 2019

https://api.elsevier.com/content/article/PII:0014296475900304?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90030-4

https://api.elsevier.com/content/article/PII:0014296475900304?httpAccept=text/plain

10 October 2023

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90030-4

European Journal of Cancer

10 October 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1132396%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1132396%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1132396%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

page(s)

1-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1132396%20AND%20SRC:MED&resulttype=core&format=json

An alteration in tumor histocompatibility induced by neuraminidase

31 August 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90030-4

Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase

10 October 2023

2

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90030-4

Regression of established methylcholanthrene tumors by intratumor injections of vibrio cholerae neuraminidase

10 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90030-4

Immunogenicity of leukemia L1210 cells after neuraminidase treatment

10 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90030-4

Active specific immunotherapy of minimal residual tumor: Excision plus neuraminidase-treated tumor cells

10 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90030-4

Neuraminidase induced loss in the transplantability of murine leukaemia L 1210, induction of immunoprotection and the transfer of induced immunity to normal DBA-2 mice by serum and peritoneal cells

10 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90030-4

Neuraminidase, sialic acids, and cell interactions

10 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90030-4

Immunogenic enhancement by neuraminidase

10 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90030-4

Comparative effect of viral and bacterial neuraminidase on the complement sensitivity of lymphoid cells

10 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90030-4

Further Studies on the Effect of Neuraminidase on Tumor Cell Transplantability

10 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90030-4

Complement sensitivity of neuraminidase-treated lymphoid cells

10 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90030-4

Activation of host lymphocytes cultured with cancer cells treated with neuraminidase

10 October 2023

32

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90030-4

Immunogenicity and antigenicity of lymphoid cells treated with neuraminidase.

10 October 2023

33

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90030-4

Failure of Neuraminidase to unmask Histocompatibility Antigens on Trophoblast

10 October 2023

34

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90030-4

STUDIES ON CELL DEFORMABILITY : I. Effect of Surface Charge

10 October 2023

36

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90030-4

10 October 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1132396%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

1 reference